Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More 05/17/13 Boston
Atlas Leans on Amgen, Novartis to Build New Startups 05/16/13 Boston
Henri Termeer on Startups, Drug Prices, Getting Older (Part 2) 05/14/13 National
Radius Health CEO: Skin Patch Data is the Value Driver 05/13/13 Boston
Henri Termeer on Startups, Drug Prices, Getting Older (Part 1) 05/13/13 National
East Coast Life Sciences Roundup: Dunsire, Good Start, Nimbus, & More 05/10/13 Boston
Nimbus Discovery, Shire to Co-Develop Oral Rare Disease Drugs 05/08/13 Boston
Will $28M in Debt Financing Push Good Start Genetics to Big Finish? 05/08/13 Boston
Concert Pharma To Get $300M+ Per Drug in Celgene Pact 05/06/13 Boston
Lessons For Drug Development From The Aveo Buzzsaw 05/06/13 National
East Coast Life Sciences Roundup: Aveo, Forma, Regeneron, RainDance, & More 05/03/13 Boston
Aveo Shares Plummet as FDA Advisory Panel Votes Down Cancer Drug 05/02/13 Boston
Boston Roundup: NEVYs, VMTurbo, Stackdriver, Cue Ball 05/02/13 Boston
Opexa Tries a Personalized Cell Therapy Against Last, Worst Stage of MS 05/02/13 Texas
Atlas Venture Raises $265M Fund, Touts Turnaround from Bloated Years 05/01/13 Boston
Aveo’s Stock Plunges As Day of Reckoning Nears For Cancer Drug 04/30/13 Boston
Three Schools, Three Startups: Boston Buzzing with Business Plan Finalists 04/30/13 Boston
Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S. 04/30/13 National
Blavatnik Gives Harvard $50M for Life Sciences Initiatives 04/29/13 Boston
Announcing Xconomy Napa Summit 2013: New Rules for Growth 04/29/13 National
RainDance Secures $20M, and a Believer in Myriad Genetics 04/29/13 Boston
Six Reasons Why Illumina Has Nothing to Fear from Thermo/Life 04/29/13 National
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
East Coast Life Sciences Roundup: Bind, Gen9, Radius, Cydan 04/26/13 Boston
Radius Health, Still Private, Raises Another $43M 04/25/13 Boston
Cydan, the NEA Startup Machine, Scours the Globe for Orphan Drugs 04/25/13 Boston
Gen9, Synthetic Biology Startup, Snags $21M from Agilent 04/24/13 Boston
Biotech Execs Aren’t Ready to Prove Drugs Have Value, E&Y Says 04/23/13 National
GlaxoSmithKline and Avalon Ventures Agree to Startup Collaboration 04/22/13 San Diego
Bind Therapeutics, AstraZeneca Collaborate on Cancer Drug 04/22/13 Boston
Page 1 of 73 next page »